Published in Nat New Biol on August 02, 1972
Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A (1982) 7.34
N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proc Natl Acad Sci U S A (1999) 3.90
Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza. Bull World Health Organ (1975) 3.88
Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J Virol (1983) 3.70
Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. J Cell Biol (1986) 3.56
The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J (1987) 3.03
pH-induced alterations in the fusogenic spike protein of Semliki Forest virus. J Cell Biol (1985) 2.98
Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. J Exp Med (1986) 2.89
Studies on the primary structure of the influenza virus hemagglutinin. Proc Natl Acad Sci U S A (1975) 2.88
Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med (1974) 2.54
Quaternary structure of influenza virus hemagglutinin after acid treatment. J Virol (1986) 2.54
Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype. Nucleic Acids Res (1983) 2.41
Conservation and variation in the hemagglutinins of Hong Kong subtype influenza viruses during antigenic drift. J Virol (1981) 2.35
A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation. Proc Natl Acad Sci U S A (1995) 2.24
Hemolytic activity of influenza virus hemagglutinin glycoproteins activated in mildly acidic environments. Proc Natl Acad Sci U S A (1983) 2.20
Antigenic drift in the hemagglutinin of the Hong Kong influenza subtype: correlation of amino acid changes with alterations in viral antigenicity. J Virol (1981) 2.09
Variant influenza virus hemagglutinin that induces fusion at elevated pH. J Virol (1986) 2.00
Influenza virus site recognized by a murine helper T cell specific for H1 strains. Localization to a nine amino acid sequence in the hemagglutinin molecule. J Exp Med (1983) 1.94
Electron microscopy of the low pH structure of influenza virus haemagglutinin. EMBO J (1986) 1.87
Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes. J Exp Med (1992) 1.82
Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc Natl Acad Sci U S A (1991) 1.79
Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO J (1995) 1.74
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68
A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group. J Hyg (Lond) (1975) 1.67
Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus. J Virol (1988) 1.67
Antigenic variation in current human type A influenza viruses: antigenic characteristics of the variants and their geographic distribution. Bull World Health Organ (1973) 1.60
Monoclonal anti-hemagglutinin antibodies detect irreversible antigenic alterations that coincide with the acid activation of influenza virus A/PR/834-mediated hemolysis. J Virol (1983) 1.59
The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores. Mol Biol Cell (2000) 1.59
Intracellular transport of soluble and membrane-bound glycoproteins: folding, assembly and secretion of anchor-free influenza hemagglutinin. EMBO J (1990) 1.58
The influenza hemagglutinin precursor as an acid-sensitive probe of the biosynthetic pathway. EMBO J (1987) 1.54
Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo. Proc Natl Acad Sci U S A (1988) 1.51
Fine structure of influenza A virus observed by electron cryo-microscopy. EMBO J (1994) 1.48
Structure and function of the influenza virus genome. Biochem J (1983) 1.47
Studies using double mutants of the conformational transitions in influenza hemagglutinin required for its membrane fusion activity. Proc Natl Acad Sci U S A (1996) 1.43
A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines. Bull World Health Organ (1975) 1.40
Morphological changes and fusogenic activity of influenza virus hemagglutinin. Biophys J (1998) 1.34
Chromatographic isolation of the hemagglutinin polypeptides from influenza virus vaccine and determination of their amino-terminal sequences. Proc Natl Acad Sci U S A (1976) 1.33
Molecular weights of the Thy-1 glycoproteins from rat thymus and brain in the presence and absence of deoxycholate. Biochem J (1978) 1.33
Antigenic variants of influenza B virus. Br Med J (1973) 1.31
Properties of an antigenic glycoprotein isolated from influenza virus hemagglutinin. J Virol (1973) 1.29
Crystallographic detection of a second ligand binding site in influenza virus hemagglutinin. Proc Natl Acad Sci U S A (1992) 1.27
Generation of a water-soluble oligomeric ectodomain of the Rous sarcoma virus envelope glycoprotein. J Virol (1993) 1.25
Quantitation and analysis of the specificity of post-immunization antibodies to influenza B viruses using single radial haemolysis. J Hyg (Lond) (1982) 1.25
Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice. J Virol (1991) 1.24
Human CD4+ T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection. J Virol (1995) 1.19
Extensive diversity in the recognition of influenza virus hemagglutinin by murine T helper clones. J Exp Med (1986) 1.18
A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins. J Hyg (Lond) (1976) 1.14
Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines. Vaccine (2011) 1.14
Inactivation of encephalomyocarditis virus in aerosols: fate of virus protein and ribonucleic acid. Appl Microbiol (1974) 1.13
The structure of a membrane fusion mutant of the influenza virus haemagglutinin. EMBO J (1990) 1.11
Highly conserved cross-reactive CD4+ T-cell HA-epitopes of seasonal and the 2009 pandemic influenza viruses. Influenza Other Respir Viruses (2010) 1.11
Role of receptor-binding activity of the viral hemagglutinin molecule in the presentation of influenza virus antigens to helper T cells. J Virol (1987) 1.00
pH-induced conformational changes of membrane-bound influenza hemagglutinin and its effect on target lipid bilayers. Protein Sci (1998) 0.99
pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion. J Virol (1999) 0.96
Distinct epitopes recognized by I-Ad-restricted T-cell clones within antigenic site E on influenza virus hemagglutinin. J Virol (1988) 0.94
pH-Controlled two-step uncoating of influenza virus. Biophys J (2014) 0.94
Mitogenicity of influenza hemagglutinin glycoproteins and influenza viruses bearing H2-hemagglutinin. Infect Immun (1981) 0.92
Tryptic peptide analysis of outer capsid polypeptides of mammalian reovirus serotypes 1, 2, and 3. J Virol (1981) 0.89
Effect of envelope proteins on the mechanical properties of influenza virus. J Biol Chem (2012) 0.87
Disulfide bonding in influenza virus proteins as revealed by polyacrylamide gel electrophoresis. J Virol (1982) 0.85
An adsorbed surface-antigen influenza vaccine and its serological activity in volunteers. Postgrad Med J (1976) 0.85
Modulation of human natural killer cytotoxicity by influenza virus and its subunit protein. Immunology (1984) 0.84
Antibodies to Mycobacterium tuberculosis-specific epitopes in lepromatous leprosy. Clin Exp Immunol (1991) 0.82
A surface antigen influenza vaccine. 2. Pyrogenicity and antigenicity. J Hyg (Lond) (1976) 0.81
The HIV-1 envelope glycoprotein structure: nailing down a moving target. Immunol Rev (2017) 0.79
In vitro enhancement of human natural cell-mediated cytotoxicity by purified influenza virus glycoproteins. J Virol (1984) 0.79
The single radial immunodiffusion assay highlights small antigenic differences among influenza virus hemagglutinins. J Clin Microbiol (1981) 0.79
A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines. Influenza Other Respir Viruses (2016) 0.78
Antigenicity in hamsters of inactivated vaccines prepared from recombinant influenza viruses. J Hyg (Lond) (1981) 0.78
The potential role of immunological adjuvants in influenza vaccines. Postgrad Med J (1973) 0.77
Conservation of determinants for class II-restricted T cells within site E of influenza virus hemagglutinin and factors influencing their expression. J Virol (1993) 0.76
Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: in vitro and in vivo study. Immunology (1983) 0.76
Alkaline-extracted influenza subunit vaccine. Infect Immun (1976) 0.75
The relative immunogenicity in mice of whole and split influenza virus. J Hyg (Lond) (1978) 0.75
Membrane-bound hemagglutinin mediates antibody and complement-dependent lysis of influenza virus-treated human platelets in autologous serum. J Clin Invest (1984) 0.75
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Atomic structure of the ectodomain from HIV-1 gp41. Nature (1997) 16.31
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
Structure of influenza haemagglutinin at the pH of membrane fusion. Nature (1994) 14.61
The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem (1987) 11.99
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature (1988) 8.32
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature (1983) 8.28
The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science (2004) 7.74
Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A (1982) 7.34
The molecular basis of the specific anti-influenza action of amantadine. EMBO J (1985) 7.08
X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc Natl Acad Sci U S A (2001) 5.92
Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell (1985) 4.84
Nucleotide sequences at the 5' termini of influenza virus RNAs and their transcripts. Nucleic Acids Res (1978) 4.83
Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell (1998) 4.73
A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A (1984) 4.37
Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity. Eur J Immunol (1977) 4.05
Transcription of the influenza virus genome. Virology (1977) 4.02
N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proc Natl Acad Sci U S A (1999) 3.90
The polypeptide composition of influenza A viruses. Virology (1971) 3.79
Studies on the in vitro transcription of reovirus RNA catalyzed by reovirus cores. Virology (1969) 3.79
Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements. Nat Struct Biol (1999) 3.72
Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell (1998) 3.69
Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses. Nature (1977) 3.67
Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. J Gen Virol (1983) 3.43
Structural basis for membrane fusion by enveloped viruses. Mol Membr Biol (1999) 3.26
The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J (1987) 3.03
Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. Biochemistry (1992) 3.03
Studies on the primary structure of the influenza virus hemagglutinin. Proc Natl Acad Sci U S A (1975) 2.88
The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells. J Exp Med (1984) 2.81
Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV. Virology (1989) 2.74
Polypeptide synthesis in influenza virus-infected cells. Virology (1972) 2.70
H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology (2004) 2.67
Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977--1978 to "Scandinavian" strains isolated in epidemics of 1950--1951. Virology (1978) 2.61
Refinement of the influenza virus hemagglutinin by simulated annealing. J Mol Biol (1990) 2.61
Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol (1984) 2.57
An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology (2002) 2.56
Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature (1995) 2.55
Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography. Virology (1997) 2.51
On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride. J Gen Virol (1978) 2.50
Interferon action--sequence specificity of the ppp(A2'p)nA-dependent ribonuclease. Nature (1981) 2.49
A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat Struct Biol (1999) 2.47
Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity. Cell (1992) 2.47
The polypeptides of adenovirus-infected cells. J Gen Virol (1972) 2.43
Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus. Nature (1998) 2.41
Characterization of influenza virus RNA complete transcripts. Virology (1982) 2.31
Influenza virus messenger RNAs are incomplete transcripts of the genome RNAs. Nucleic Acids Res (1977) 2.26
A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation. Proc Natl Acad Sci U S A (1995) 2.24
Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study. Biochemistry (1989) 2.24
The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide. EMBO J (1996) 2.21
Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion. J Gen Virol (1988) 2.21
Virus replication in enucleate cells: vesicular stomatitis virus and influenza virus. J Virol (1974) 2.19
Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes. Virology (1986) 2.13
Molecular basis of resistance of influenza A viruses to amantadine. J Antimicrob Chemother (1986) 2.04
Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci U S A (2001) 2.04
Structural evidence for recognition of a single epitope by two distinct antibodies. Proteins (2000) 1.99
Studies on the adaptation of influenza viruses to MDCK cells. EMBO J (1984) 1.98
Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin. J Virol (1995) 1.96
Studies of the binding properties of influenza hemagglutinin receptor-site mutants. Virology (1998) 1.95
Evidence from studies with a cross-linking reagent that the haemagglutinin of influenza virus is a trimer. Virology (1977) 1.93
Host-mediated selection of influenza virus receptor variants. Sialic acid-alpha 2,6Gal-specific clones of A/duck/Ukraine/1/63 revert to sialic acid-alpha 2,3Gal-specific wild type in ovo. J Biol Chem (1985) 1.91
Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains. Proc Natl Acad Sci U S A (1983) 1.88
Antigen distortion allows influenza virus to escape neutralization. Nat Struct Biol (1998) 1.88
Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies. Virology (2000) 1.87
Electron microscopy of the low pH structure of influenza virus haemagglutinin. EMBO J (1986) 1.87
rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells. J Virol (1983) 1.81
Mechanism of neutralization of influenza virus infectivity by antibodies. Virology (2002) 1.80
Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc Natl Acad Sci U S A (1991) 1.79
Studies of influenza haemagglutinin-mediated membrane fusion. Virology (1986) 1.78
Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO J (1995) 1.74
Estimations of the molecular weight of the influenza virus genome. J Gen Virol (1971) 1.74
Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin. Nature (1984) 1.72
Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virus. J Virol (1987) 1.70
Membrane fusion by peptide analogues of influenza virus haemagglutinin. J Gen Virol (1988) 1.69
Avian and human receptor binding by hemagglutinins of influenza A viruses. Glycoconj J (2006) 1.66
Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera. J Virol (1986) 1.65
Antigenic analyses of influenza virus haemagglutinins with different receptor-binding specificities. Virology (1984) 1.64
Nucleotide sequences at the terminal of La Crosse virus RNAs. Nucleic Acids Res (1980) 1.61
The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil. Proc Natl Acad Sci U S A (1998) 1.58
The matrix protein gene determines amantadine-sensitivity of influenza viruses. J Gen Virol (1979) 1.54
Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no effect on membrane fusion properties. Virology (1991) 1.50
Proteins synthesized in chick cells following infection with Semliki Forest virus. J Gen Virol (1968) 1.50
The preparation and properties of adenovirus cores. J Gen Virol (1971) 1.49
Recognition of influenza A virus nucleoprotein by an H-2-restricted cytotoxic T-cell clone. Virology (1984) 1.48
Structure of the haemagglutinin of influenza virus. Br Med Bull (1979) 1.47
Studies using double mutants of the conformational transitions in influenza hemagglutinin required for its membrane fusion activity. Proc Natl Acad Sci U S A (1996) 1.43
RNA-dependent RNA polymerase activity of the influenza virus. Virology (1971) 1.43
Studies on relationships between human and porcine influenza. 1. Serological evidence of infection in swine in Great Britain with an influenza A virus antigenically like human Hong Kong-68 virus. Bull World Health Organ (1972) 1.40
The immune response of BALB/c mice to influenza hemagglutinin: commonality of the B cell and T cell repertoires and their relevance to antigenic drift. Eur J Immunol (1989) 1.39
Early polypeptide synthesis in influenza virus-infected cells. Virology (1973) 1.38
Influenza A specific cytotoxic T-cell clones that do not recognize viral glycoproteins. Nature (1982) 1.38
Conformational-dependent recognition of influenza virus hemagglutinin by murine T helper clones. Eur J Immunol (1986) 1.37
The size and shape of influenza virus neuraminidase. Virology (1973) 1.36
Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli. Proc Natl Acad Sci U S A (1997) 1.35
Structural basis for oseltamivir resistance of influenza viruses. Vaccine (2009) 1.31
In vitro synthesis, glycosylation, and membrane insertion of influenza virus haemagglutinin. Virology (1979) 1.31
Focused ion beam-scanning electron microscope: exploring large volumes of atherosclerotic tissue. J Microsc (2009) 1.30
A surface plasmon resonance assay for the binding of influenza virus hemagglutinin to its sialic acid receptor. Virology (1996) 1.29
Crystallographic detection of a second ligand binding site in influenza virus hemagglutinin. Proc Natl Acad Sci U S A (1992) 1.27
Induction and characterization of delayed-type hypersensitivity to influenza virus in mice. Eur J Immunol (1979) 1.26